Ginger M. Jones
Ginger M. Jones's purchase track record
Ginger M. Jones has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/13/2023 | HLLY | $38K | +39.5% | +5.7% | +18.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Goldman Sachs Lowers Tronox Price Target to $4. Goldman Sachs has maintained a Sell rating on Tronox Holdings while lowering its price target to $4. This move follows the company's release of its Q2 2026 earnings report. The new target is below the current average analyst estimate of $5.50, reflecting a more cautious outlook from the bank.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Nordson Packaging Recovery Cited Amid Valuation Concerns. Recent commentary highlights a genuine recovery in Nordson's packaging segment, though analysts note the stock price reflects this optimism. The company trades at a trailing P/E of 32.8, which some view as a premium relative to its current valuation. With the stock near its 52-week high, the market is closely watching whether operational improvements can justify the current price point.
Transaction History
| HLLY | ▲ Buy | Grant | 32,710 | $0 | 5/8/2026 | View on chart |
| TROX | ▼ Sell | Tax Withholding | 3,335 | $33K | 4/28/2026 | View on chart |
| TROX | ▲ Buy | Grant | 15,690 | $0 | 4/28/2026 | View on chart |
| NDSN | ▲ Buy | Grant | 822 | $191K | 11/1/2025 | View on chart |
| HLLY | ▲ Buy | Grant | 48,165 | $0 | 5/13/2025 | View on chart |
| TROX | ▼ Sell | Tax Withholding | 721 | $4K | 5/7/2025 | View on chart |
| TROX | ▲ Buy | Grant | 27,223 | $0 | 5/7/2025 | View on chart |
| NDSN | ▲ Buy | Grant | 747 | $186K | 11/1/2024 | View on chart |
| HLLY | ▲ Buy | Grant | 29,166 | $0 | 6/10/2024 | View on chart |
| TROX | ▼ Sell | Tax Withholding | 1,248 | $24K | 5/8/2024 | View on chart |
| TROX | ▲ Buy | Grant | 8,324 | $0 | 5/8/2024 | View on chart |
| HLLY | ▲ Buy | Open Market | 10,000 | $38K | 11/13/2023 | View on chart |
| NDSN | ▲ Buy | Grant | 749 | $158K | 11/1/2023 | View on chart |
| HLLY | ▲ Buy | Grant | 34,979 | $0 | 5/9/2023 | View on chart |
| TROX | ▼ Sell | Tax Withholding | 1,072 | $14K | 5/3/2023 | View on chart |
| TROX | ▲ Buy | Grant | 11,261 | $0 | 5/3/2023 | View on chart |
| NDSN | ▲ Buy | Grant | 730 | $165K | 11/1/2022 | View on chart |
| TROX | ▲ Buy | Grant | 8,537 | $0 | 5/12/2022 | View on chart |
| HLLY | ▲ Buy | Grant | 9,320 | $0 | 5/11/2022 | View on chart |
| NDSN | ▲ Buy | Grant | 608 | $145K | 11/1/2021 | View on chart |
| HLLY | ▲ Buy | Grant | 17,000 | $0 | 9/23/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Holley Reports $125M Debt Prepayment Since 2023
Holley Inc. announced it continues to reduce its debt load, with total repayments reaching $125 million since 2023. This move to deleverage is a key financial update for the company, separate from broader industry pressures seen in other automotive suppliers. The stock is currently trading near its support levels, reflecting ongoing market caution despite the improved balance sheet.
Holley Reports $125M Debt Prepayment Since 2023. Holley Inc. announced it continues to reduce its debt load, with total repayments reaching $125 million since 2023. This move to deleverage is a key financial update for the company, separate from broader industry pressures seen in other automotive suppliers. The stock is currently trading near its support levels, reflecting ongoing market caution despite the improved balance sheet.